lactic acid has been researched along with substance p in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (7.69) | 18.7374 |
1990's | 2 (15.38) | 18.2507 |
2000's | 4 (30.77) | 29.6817 |
2010's | 6 (46.15) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Rozsa, Z; Varro, V | 1 |
Beal, MF; Brouillet, E; Henshaw, R; Hyman, BT; Jenkins, B; Rosen, B | 1 |
Garry, MG; Geier, HE; Hargreaves, KM; Jackson, DL; Southam, M | 1 |
Gardemann, A; Jungermann, K; Lüers, C; Miura, H | 1 |
Geisslinger, G; Meller, ST; Tegeder, L; Zimmermann, J | 1 |
Berg, M; Edström, DW; Lonne-Rahm, S; Nordlind, K; Ros, AM | 1 |
Ji, HR; Pang, XD; Xiao, G; Xu, XX; Yan, JJ; Yang, CD; Yu, DH; Zhang, ZW; Zhu, D | 1 |
Atala, A; Chen, T; Ju, YM; Ko, IK; Lee, SJ; Yoo, JJ | 1 |
Desai, PR; Shah, PP; Singh, M | 1 |
Bäckryd, E; Gerdle, B; Ghafouri, B; Ghafouri, N; Karlsson, L; Larsson, B; Olausson, P | 1 |
Almeida, T; Díaz, C; Ferreres, J; Hernández, M; Jiménez, A; Labarta, L; Lorente, L; Martín, MM; Solé-Violán, J | 1 |
Jung, Y; Kim, JE; Kim, SH | 1 |
Buscaglia, P; Carré, JL; Gouin, O; L'herondelle, K; Le Gall-Ianotto, C; Lebonvallet, N; Leschiera, R; Mignen, O; Misery, L; Philbé, JL; Saguet, T; Sakka, M | 1 |
2 trial(s) available for lactic acid and substance p
Article | Year |
---|---|
Release of algesic substances in human experimental muscle pain.
Topics: Adult; Arm; Dinoprostone; Exercise; Female; Glutamic Acid; Humans; Hypertonic Solutions; Inflammation; Lactic Acid; Leg; Male; Microdialysis; Muscle Contraction; Muscle Fatigue; Muscle, Skeletal; Nitric Oxide; Pain; Pain Measurement; Sodium Chloride; Substance P; Time Factors | 2002 |
Laser treatment of rosacea: a pathoetiological study.
Topics: Adult; Aged; Calcitonin Gene-Related Peptide; Dermis; Epidermis; Female; Humans; Immunohistochemistry; Lactic Acid; Laser Therapy; Lip; Male; Middle Aged; Nose; Rosacea; Substance P; Ubiquitin Thiolesterase; Vasoactive Intestinal Peptide | 2004 |
11 other study(ies) available for lactic acid and substance p
Article | Year |
---|---|
Mechanism of "substance P": on mesenteric blood flow; interactions with opioid peptides.
Topics: Acetylcholine; Animals; Atropine; Dogs; Dose-Response Relationship, Drug; Endorphins; Female; Hexamethonium; Hexamethonium Compounds; Lactates; Lactic Acid; Male; Naloxone; Oxygen Consumption; Splanchnic Circulation; Substance P | 1987 |
Age-dependent striatal excitotoxic lesions produced by the endogenous mitochondrial inhibitor malonate.
Topics: Adenosine Triphosphate; Aging; Animals; Corpus Striatum; Dizocilpine Maleate; gamma-Aminobutyric Acid; Lactates; Lactic Acid; Magnetic Resonance Imaging; Male; Malonates; Mitochondria; Neurotoxins; Oxidation-Reduction; Rats; Rats, Sprague-Dawley; Somatostatin; Substance P | 1993 |
Evaluation of the efficacy of a bioerodible bupivacaine polymer system on antinociception and inflammatory mediator release.
Topics: Anesthetics, Local; Animals; Biocompatible Materials; Biodegradation, Environmental; Bradykinin; Bupivacaine; Drug Implants; Immunohistochemistry; Inflammation Mediators; Lactic Acid; Male; Microdialysis; Pain; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Rats; Rats, Sprague-Dawley; Substance P | 1999 |
Neuropeptide Y and peptide YY, but not pancreatic polypeptide, substance P, cholecystokinin and gastric inhibitory polypeptide, inhibit the glucagon- and noradrenaline-dependent increase in glucose output in rat liver.
Topics: Animals; Cholecystokinin; Gastric Inhibitory Polypeptide; Glucagon; Glucose; Infusions, Intravenous; Lactic Acid; Liver; Liver Circulation; Male; Neuropeptide Y; Norepinephrine; Pancreatic Polypeptide; Peptide YY; Rats; Rats, Wistar; Substance P | 2000 |
[Experimental study on the prevention of epidural scar adhesion with polycaprolactone/polylactic acid membrane].
Topics: Animals; Biocompatible Materials; Cicatrix; Female; Lactic Acid; Laminectomy; Membranes, Artificial; Polyesters; Polymers; Postoperative Complications; Prosthesis Implantation; Proto-Oncogene Proteins c-fos; Rats; Rats, Wistar; Spinal Cord; Spinal Diseases; Substance P; Tissue Adhesions | 2004 |
Combined systemic and local delivery of stem cell inducing/recruiting factors for in situ tissue regeneration.
Topics: Animals; Cells, Cultured; Chemokine CXCL12; Chemotaxis; Drug Delivery Systems; Flow Cytometry; Gelatin; Lactic Acid; Male; Mice; Mice, Inbred Strains; Neovascularization, Physiologic; Neurotransmitter Agents; Polyesters; Polymers; Proto-Oncogene Proteins c-kit; Regeneration; Stem Cells; Substance P; Tissue Engineering; Tissue Scaffolds | 2012 |
Effect of oleic acid modified polymeric bilayered nanoparticles on percutaneous delivery of spantide II and ketoprofen.
Topics: Administration, Cutaneous; Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Dermatitis, Allergic Contact; Dinitrofluorobenzene; Humans; Ketoprofen; Lactic Acid; Male; Mice; Mice, Inbred C57BL; Nanoparticles; Oleic Acid; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Skin; Skin Absorption; Substance P; Succinimides | 2012 |
Intramuscular pain modulatory substances before and after exercise in women with chronic neck pain.
Topics: Adult; beta-Endorphin; Chronic Disease; Exercise Therapy; Female; Glutamic Acid; Humans; Hydrocortisone; Lactic Acid; Microdialysis; Middle Aged; Neck Pain; Pain Measurement; Pain Threshold; Pyruvic Acid; Shoulder Pain; Substance P; Superficial Back Muscles; Young Adult | 2015 |
Association between serum substance P levels and mortality in patients with severe sepsis.
Topics: Aged; Biomarkers; Critical Care; Female; Humans; Intensive Care Units; Kaplan-Meier Estimate; Lactic Acid; Male; Middle Aged; Odds Ratio; Organ Dysfunction Scores; Prognosis; Prospective Studies; Sepsis; Substance P | 2015 |
Substance P/dexamethasone-encapsulated PLGA scaffold fabricated using supercritical fluid process for calvarial bone regeneration.
Topics: Adult; Animals; Bone Regeneration; Cell Separation; Computer Systems; Dexamethasone; Female; Flow Cytometry; Humans; Lactic Acid; Male; Middle Aged; Neovascularization, Physiologic; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats, Sprague-Dawley; Skull; Substance P; Tissue Scaffolds; X-Ray Microtomography | 2017 |
A new tool to test active ingredient using lactic acid in vitro, a help to understand cellular mechanism involved in stinging test: An example using a bacterial polysaccharide (Fucogel
Topics: Acid Sensing Ion Channels; Adult; Aged; Animals; Carrier Proteins; Coculture Techniques; Female; Humans; Hydrogen-Ion Concentration; Keratinocytes; Lactic Acid; Middle Aged; Nerve Tissue Proteins; Pain; PC12 Cells; Polysaccharides, Bacterial; Rats; Skin; Substance P; TRPV Cation Channels; Young Adult | 2018 |